trial · primary record
Anticoagulant Therapy
Pulmonary Embolism
| Phase | Phase 3 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 500 |
| Primary completion | 2027-08-04 |
| Primary endpoint | Peak Oxygen Consumption (PVO2) |
| Registry ID | NCT05591118 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T13:43:49.600Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05591118
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.